Wearable Injectors Market Size Anticipated to Reach USD 12 billion by 2035

Wearable injectors market growth is anticipated at a CAGR of 9% during the period 2023-2035

 

According to a recently published report by Roots Analysis, the increasing prevalence of chronic diseases and requirement for emergency medical interventions is driving wearable injectors market growth

Wearable Injectors Industry Overview

The global wearable injectors market is anticipated to grow at a CAGR of 9% from 2023-2035, reaching US$12.10 billion by 2035

In recent years, the pharmaceutical industry has undergone significant technological advancements, particularly with the emergence of novel drug delivery devices, including wearable injectors. These compact, portable self-injection devices are specifically designed to enable the subcutaneous delivery of substantial drug volumes. Among them, on-body injectors have garnered attention for their ability to provide sustained therapeutic effects, thereby enhancing patient adherence and treatment effectiveness. Typically, these injection systems comprise two primary components: the main pump unit, which houses the drug reservoir, and the medication delivery unit. Depending on the device's complexity, either one or both of these components can be worn by the patient. Wearable injectors allow for the convenient self-administration of large doses over a pre-set delivery period, aiming to address concerns related to injection site issues and pain. This technological innovation holds promise for improving the delivery and efficacy of various drug therapies, benefiting both patients and healthcare providers.

To order this 680+ page report, which features 400+ figures and 650+ tables, please visit https://www.rootsanalysis.com/reports/large-volume-wearable-injectors/238.html

Market Drivers

Various factors contribute to the market growth of wearable injectors devices. These include the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, which has led to the rise in the demand for large volume wearable injectors. These devices are ideal for patients requiring frequent injections as they can effectively administer large volumes of medication over an extended period. Furthermore, continuous innovation in wearable injector technologies, including improvements in design, functionality, and usability, has led to an increase in their demand. Advancements, such as improved needle insertion mechanisms and enhanced dosing accuracy have made them more user-friendly and reliable. Additionally, large volume wearable injectors can help reduce healthcare costs by shifting treatment from hospitals or healthcare facilities to home settings, resulting in cost savings for both patients and healthcare.

Market Restraints

One of the primary restraints associated with this industry is regulatory compliance challenges. The wearable injectors market faces regulatory hurdles related to safety, efficacy, and quality assurance. Ensuring compliance with regulations, such as FDA’s 510(k) clearance and CE marking can be complex and time-consuming. Additionally, site irritation and skin reactions are common concerns associated with wearable injectors due to prolonged exposure to the device and the medication. These issues include patients' discomfort and reduced adherence. Furthermore, patients may struggle to properly operate the device, leading to adverse effects, reduced efficacy, and increased healthcare costs. Manufacturers need to prioritize user-centered design and provide comprehensive training to the patients.

Growth Factors

Despite the challenges, several growth factors continue to drive the wearable injectors market forward. One notable factor is the growing demand for home healthcare. Patients prefer to receive treatment at home, and wearable injectors enable the administration of high volumes of medication over extended, making them ideal for home use. In addition, the rising investments in R&D by manufacturers is driving innovation in wearable injectors market leading to development of more user-friendly devices. Further, the increasing adoption of self-administration of medication is driving the demand as patients prefer to have control over their treatment.

Wearable injectors Market Segments

Based on the application, the market is segmented into insulin and non-insulin drug delivery

• The insulin segment in wearable injectors market captures the largest revenue share of 97.46% in 2023.
• In fact, non-insulin segment is anticipated to show the highest market growth potential during the forecast period of over 9.99% annually.

Based on the type of device, the market is segmented into patch pump and infusion pump

• The infusion segment led the wearable injectors market, capturing the largest revenue share of close to 80.0% in 2023.
• The patch pump segment is anticipated to show the highest market growth potential during the forecast period of over 14% annually.

Based on the usability, the market is segmented into reusable (disposable components) and disposable

• The reusable (disposable components) segment led the wearable injectors market, capturing the largest revenue share of more than 55.0% in 2023.
• The reusable (disposable components) segment is anticipated to show the highest growth potential by growing at a CAGR of over 10.0% during the forecast period.

Based on the therapeutic area, the market is segmented into autoimmune disorders, cardiovascular disorders, metabolic disorders, neurological disorders, oncological disorders and
other disorders

• The oncological disorder segment led the wearable injectors market, capturing the largest revenue share of more than 62.0% in 2023.
• The autoimmune disorder segment is anticipated to show the highest growth potential by growing at a CAGR of 11.89% during the forecast period.

Based on the Regional Insights, the market is segmented into US, Canada, UK, Germany, Spain, Italy, France, China, Japan, India, Israel and Brazil

• The US dominated the wearable injectors market and accounted for the largest revenue share of over 45.0% in 2023.
• In China and Japan, the wearable injectors market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The wearable injectors market report also includes detailed profiles of key players (listed below) that offer wearable injectors products:

• CCBio
• CeQur
• Debiotech
• E3D Elcam Drug Delivery Devices
• Eli Lilly
• Enable Injections
• Gerresheimer
• Insulet
• Medtronic
• Medtrum Technologies
• Pharmasense
• Roche
• Sonceboz
• Weibel CDS
• West Pharmaceuticals
• SOOIL Development

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/large-volume-wearable-injectors/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com